Research across borders

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find studies Explore world registries Peptide directory

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 18:18 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Not applicableCompletedINTERVENTIONAL

Carbetocin Versus Oxytocin and Ergometrine for the Prevention of Postpartum Hemorrhage

ClinicalTrials.gov · NCT03578263 · Registry updated: 2020-08-05

Condition / research focus: Cesarean Section Complications
Sponsor: Aswan University Hospital
Countries with listed sites: Egypt
Registry dates and results: Start: 2018-04-01. Completion: 2020-08-01 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug) — also listed as: Pabal
oxytocin (drug) — also listed as: Active Comparator
ergometrine (drug) — also listed as: Active Comparator

Where the study takes place — 1 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

AswanUH
Aswān, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2 / Phase 3CompletedINTERVENTIONAL

Misoprostol+Oxytocin vs. Carbetocin in CS

ClinicalTrials.gov · NCT02786992 · Registry updated: 2020-07-08

Condition / research focus: Cesarean Section
Sponsor: Ain Shams University
Countries with listed sites: Egypt
Registry dates and results: Start: 2016-05. Completion: 2020-01 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Misoprostol (drug) — also listed as: Mesotec, Mesotac
Oxytocin (drug) — also listed as: Syntocinon
Carbetocin (drug) — also listed as: Pabal
Placebo (drug)

Where the study takes place — 1 listed sites

Ain Shams University Maternity Hospital
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Intravenous Tranexamic Acid Versus IV Carbetocin in Abdominal Myomectomy

ClinicalTrials.gov · NCT04357015 · Registry updated: 2020-04-22

Condition / research focus: Myomectomy
Sponsor: Cairo University
Countries with listed sites: No country reported
Registry dates and results: Start: 2020-05-01. Completion: 2020-10-20 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

intravenous tranexamic acid (drug)
intravenous carbetocin (drug)
placebo (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

the Effect of Carbetocin in Decreasing Intraoperative Blood Loss in Abdominal Myomectomy

ClinicalTrials.gov · NCT04083625 · Registry updated: 2020-04-08

Condition / research focus: Abdominal Myomectomy
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2019-09-10. Completion: 2020-02-20 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

carbetocin 100 mcg (drug)
placebo (drug)

Where the study takes place — 1 listed sites

Giza hospital
Giza, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Carbetocin Versus Misoprostol. A Retrospective Comparative Study

ClinicalTrials.gov · NCT04313218 · Registry updated: 2020-03-18

Condition / research focus: Cesarean Section Complications
Sponsor: Port Said University hospital
Countries with listed sites: Egypt
Registry dates and results: Start: 2018-01-01. Completion: 2020-02-28 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug) — also listed as: misoprostol

Where the study takes place — 1 listed sites

Waleed Elsayed Elrefaie
Port Said, NY, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Carbetocin Versus Ergometrin in the Prevention of Postpartum Hemorrhage

ClinicalTrials.gov · NCT04300452 · Registry updated: 2020-03-09

Condition / research focus: Postpartum Hemorrhage
Sponsor: National and Kapodistrian University of Athens
Countries with listed sites: Greece
Registry dates and results: Start: 2018-04-05. Completion: 2020-09-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug) — also listed as: Pabal
Ergometrine Maleate (drug) — also listed as: Mitrotan

Where the study takes place — 1 listed sites

Hospital "Elena Venizelou"
Athens, Attica, Greece
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Carbetocin Versus Syntometrine in Obese Women Undergoing Elective Cesarean

ClinicalTrials.gov · NCT03693599 · Registry updated: 2020-01-03

Condition / research focus: Post Partum Hemorrhage
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2018-10-01. Completion: 2019-09-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

carbetocin (drug)
Syntometrine (drug)

Where the study takes place — 1 listed sites

faculty of medicine Cairo university
Giza, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

CARBETOCIN VERSUS RECTAL MISOPROSTOL FOR MANAGEMENT OF THIRD STAGE OF LABOR IN WOMEN AT LOW RISK OF POSTPARTUM HEMORRHAGE

ClinicalTrials.gov · NCT03556852 · Registry updated: 2019-10-11

Condition / research focus: Postpartum Hemorrhage
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2018-07-02. Completion: 2019-05-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug)
Misoprostol (drug)

Where the study takes place — 1 listed sites

Kasr Alainy medical school
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Early Phase 1CompletedINTERVENTIONAL

Carbetocin Versus Oxytocin for Prevention of Postcesarean Hemorrhage in Pregnancy With High Risk for PPH

ClinicalTrials.gov · NCT04089176 · Registry updated: 2019-09-13

Condition / research focus: Postpartum Hemorrhage; Cesarean Section; High Risk Pregnancy
Sponsor: Department of Medical Services Ministry of Public Health of Thailand
Countries with listed sites: Thailand
Registry dates and results: Start: 2019-02-01. Completion: 2019-05-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug)
oxytocin (drug)

Where the study takes place — 1 listed sites

Rajavithi Hospital
Bangkok, Thailand
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Carbetocin at Elective Cesarean Deliveries: A Dose-finding Study in Women With BMI ≥ 40kg/m2

ClinicalTrials.gov · NCT03672045 · Registry updated: 2019-06-07

Condition / research focus: Postpartum Hemorrhage
Sponsor: Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Countries with listed sites: Canada
Registry dates and results: Start: 2018-11-19. Completion: 2019-05-17 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug) — also listed as: Duratocin

Where the study takes place — 1 listed sites

Mount Sinai Hospital
Toronto, Ontario, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Database Evaluating Outcomes of Using Carbetocin as the Primary Uterotonic Following Cesarean Delivery

ClinicalTrials.gov · NCT03959436 · Registry updated: 2019-05-29

Condition / research focus: Carbetocin; Cesarean Section Complications; Uterotonics; Uterine Atony With Hemorrhage
Sponsor: Maisonneuve-Rosemont Hospital
Countries with listed sites: Canada
Registry dates and results: Start: 2017-03-29. Completion: 2018-03-16 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug) — also listed as: Duratocin

Where the study takes place — 1 listed sites

Maisonneuve-Rosemont hospital
Montreal, Quebec, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableUnknownOBSERVATIONAL

Effects of Oxytocin and Carbetocin on Renal System in Cesarean Sections

ClinicalTrials.gov · NCT03939806 · Registry updated: 2019-05-13

Condition / research focus: Postpartum Hemorrhage
Sponsor: Ufuk University
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2019-05. Completion: 2019-06 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
Carbetocin (drug)

Where the study takes place — 1 listed sites

Ufuk University Faculty of Medicine Hospital
Ankara, Balgat, Turkey (Türkiye)
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Carbetocin Versus Oxytocin Infusion Plus Tranexamic Acid During Cesarean Section

ClinicalTrials.gov · NCT03777878 · Registry updated: 2019-02-15

Condition / research focus: Cesarean Section Complications
Sponsor: Aswan University Hospital
Countries with listed sites: Egypt
Registry dates and results: Start: 2019-01-01. Completion: 2021-05-01 (may be estimated). No results posted in this registry response.

Products and interventions (6)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug) — also listed as: Active Comparator
oxytocin (drug) — also listed as: Active Comparator
TA (drug) — also listed as: active comparator
placebo to carbetocin (drug) — also listed as: placebo comparator
placebo to TA (drug) — also listed as: placebo comparator
placebo to oxytocin (drug) — also listed as: placebo comparator

Where the study takes place — 1 listed sites

Aswan University
Aswān, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Carbetocin Versus Oxytocin for the Prevention of Postpartum Hemorrhage in Emergency Caesarean Delivery

ClinicalTrials.gov · NCT03755531 · Registry updated: 2018-11-28

Condition / research focus: Postpartum Hemorrhage (Primary)
Sponsor: Al-Kindy College of Medicine
Countries with listed sites: Iraq
Registry dates and results: Start: 2018-01-04. Completion: 2018-08-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug) — also listed as: BABAL
Oxytocin (drug) — also listed as: Pitocin

Where the study takes place — 1 listed sites

Al Kindy College of Medicine/ University of Baghdad
Baghdad, Iraq
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Intramuscular Oxytocics: A Randomised Control Trial

ClinicalTrials.gov · NCT02216383 · Registry updated: 2018-11-14

Condition / research focus: Post Partum Haemorrhage
Sponsor: North Bristol NHS Trust
Countries with listed sites: United Kingdom
Registry dates and results: Start: 2015-02. Completion: 2018-10-30 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug) — also listed as: Pabal
Syntocinon (drug) — also listed as: Oxytocin
Syntometrine (drug) — also listed as: Syntometrine 500 micrograms/5 IU Solution for Injection

Where the study takes place — 5 listed sites

North Bristol NHS Trust
Bristol, Avon, United Kingdom
Site recruitment: Not reported
Gloucestershire Hospitals NHS Trust
Gloucester, Gloucestershire, United Kingdom
Site recruitment: Not reported
Royal United Hospital NHS Trust
Bath, Somerset, United Kingdom
Site recruitment: Not reported
Nottingham University Hospitals NHS Trust
Nottingham, United Kingdom
Site recruitment: Not reported
Great Western Hospital
Swindon, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Effect of the Uterotonic Carbetocin on Acute Post Cesarean-Section Pain

ClinicalTrials.gov · NCT02642263 · Registry updated: 2018-05-04

Condition / research focus: Cesarean Delivery
Sponsor: Insel Gruppe AG, University Hospital Bern
Countries with listed sites: Switzerland
Registry dates and results: Start: 2019-02-01. Completion: 2022-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug) — also listed as: Pabal, Ferring, Baar, Switzerland

Where the study takes place — 1 listed sites

Dep. of Anesthesiology and Pain Medicine, Bern University Hospital
Bern, Switzerland
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Carbetocin Trial: Carbetocin Appropriate Rate Better Equilibrium Between Tonus (TOnus) and CIrculatioN

ClinicalTrials.gov · NCT02221531 · Registry updated: 2018-01-09

Condition / research focus: Complications; Cesarean Section; Anesthesia; Reaction
Sponsor: University Hospital, Basel, Switzerland
Countries with listed sites: Switzerland
Registry dates and results: Start: 2014-08. Completion: 2015-11 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin Short-infusion (drug)
Carbetocin Bolus application (drug)

Where the study takes place — 1 listed sites

University Hospital Basel
Basel, Switzerland
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Prevention of Postpartum Hemorrhage in Patients With Severe Preeclampsia Using Carbetocin Versus Misoprostol

ClinicalTrials.gov · NCT02086994 · Registry updated: 2017-02-15

Condition / research focus: Severe Pre-eclampsia, Postpartum Condition or Complication
Sponsor: khalid abd aziz mohamed
Countries with listed sites: Egypt
Registry dates and results: Start: 2013-03. Completion: 2015-08 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

misoprostol (drug) — also listed as: misoprost, cytotec, misotec
carbetocin (drug) — also listed as: pabal

Where the study takes place — 1 listed sites

Benha univesity hospital
Banhā, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Carbetocin and Oxytocin in Elective Caesarean Section With High Risk of Postpartum Hemorrhage

ClinicalTrials.gov · NCT02391636 · Registry updated: 2017-01-25

Condition / research focus: Postpartum Hemorrhage
Sponsor: Ghamra Military Hospital
Countries with listed sites: Egypt
Registry dates and results: Start: 2015-02. Completion: 2016-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug) — also listed as: Pabal
Oxytocin (drug) — also listed as: Syntocinon

Where the study takes place — 1 listed sites

Ghamra Military Hospital
Cairo, Cairo Governorate, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3UnknownINTERVENTIONAL

Carbetocin Versus Oxytocin in the Prevention of Post Partum Haemorrhage (PPH) in Women Undergoing Caesarean Sections for Placenta Previa: A Randomised Controlled Trial

ClinicalTrials.gov · NCT02303418 · Registry updated: 2017-01-23

Condition / research focus: Post Partum Haemorrhage
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2014-11. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug)
Oxytocin (drug)

Where the study takes place — 2 listed sites

BeniSuef University hospitals
BeniSuef, Egypt
Site recruitment: Recruiting
Cairo university hospitals
Cairo, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Worldwide

Africa

Pan African Clinical Trial Registry ↗

Americas

Asia

Middle East

Europe

Oceania

Australia / New Zealand — ANZCTR ↗

Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.

Worldwide Study Finder

Loading registry information…

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 18:18 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Not applicableCompletedINTERVENTIONAL

Carbetocin Versus Oxytocin and Ergometrine for the Prevention of Postpartum Hemorrhage

ClinicalTrials.gov · NCT03578263 · Registry updated: 2020-08-05

Condition / research focus: Cesarean Section Complications
Sponsor: Aswan University Hospital
Countries with listed sites: Egypt
Registry dates and results: Start: 2018-04-01. Completion: 2020-08-01 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug) — also listed as: Pabal
oxytocin (drug) — also listed as: Active Comparator
ergometrine (drug) — also listed as: Active Comparator

Where the study takes place — 1 listed sites

AswanUH
Aswān, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2 / Phase 3CompletedINTERVENTIONAL

Misoprostol+Oxytocin vs. Carbetocin in CS

ClinicalTrials.gov · NCT02786992 · Registry updated: 2020-07-08

Condition / research focus: Cesarean Section
Sponsor: Ain Shams University
Countries with listed sites: Egypt
Registry dates and results: Start: 2016-05. Completion: 2020-01 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Misoprostol (drug) — also listed as: Mesotec, Mesotac
Oxytocin (drug) — also listed as: Syntocinon
Carbetocin (drug) — also listed as: Pabal
Placebo (drug)

Where the study takes place — 1 listed sites

Ain Shams University Maternity Hospital
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Intravenous Tranexamic Acid Versus IV Carbetocin in Abdominal Myomectomy

ClinicalTrials.gov · NCT04357015 · Registry updated: 2020-04-22

Condition / research focus: Myomectomy
Sponsor: Cairo University
Countries with listed sites: No country reported
Registry dates and results: Start: 2020-05-01. Completion: 2020-10-20 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

intravenous tranexamic acid (drug)
intravenous carbetocin (drug)
placebo (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

the Effect of Carbetocin in Decreasing Intraoperative Blood Loss in Abdominal Myomectomy

ClinicalTrials.gov · NCT04083625 · Registry updated: 2020-04-08

Condition / research focus: Abdominal Myomectomy
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2019-09-10. Completion: 2020-02-20 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

carbetocin 100 mcg (drug)
placebo (drug)

Where the study takes place — 1 listed sites

Giza hospital
Giza, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Carbetocin Versus Misoprostol. A Retrospective Comparative Study

ClinicalTrials.gov · NCT04313218 · Registry updated: 2020-03-18

Condition / research focus: Cesarean Section Complications
Sponsor: Port Said University hospital
Countries with listed sites: Egypt
Registry dates and results: Start: 2018-01-01. Completion: 2020-02-28 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug) — also listed as: misoprostol

Where the study takes place — 1 listed sites

Waleed Elsayed Elrefaie
Port Said, NY, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Carbetocin Versus Ergometrin in the Prevention of Postpartum Hemorrhage

ClinicalTrials.gov · NCT04300452 · Registry updated: 2020-03-09

Condition / research focus: Postpartum Hemorrhage
Sponsor: National and Kapodistrian University of Athens
Countries with listed sites: Greece
Registry dates and results: Start: 2018-04-05. Completion: 2020-09-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug) — also listed as: Pabal
Ergometrine Maleate (drug) — also listed as: Mitrotan

Where the study takes place — 1 listed sites

Hospital "Elena Venizelou"
Athens, Attica, Greece
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Carbetocin Versus Syntometrine in Obese Women Undergoing Elective Cesarean

ClinicalTrials.gov · NCT03693599 · Registry updated: 2020-01-03

Condition / research focus: Post Partum Hemorrhage
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2018-10-01. Completion: 2019-09-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

carbetocin (drug)
Syntometrine (drug)

Where the study takes place — 1 listed sites

faculty of medicine Cairo university
Giza, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

CARBETOCIN VERSUS RECTAL MISOPROSTOL FOR MANAGEMENT OF THIRD STAGE OF LABOR IN WOMEN AT LOW RISK OF POSTPARTUM HEMORRHAGE

ClinicalTrials.gov · NCT03556852 · Registry updated: 2019-10-11

Condition / research focus: Postpartum Hemorrhage
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2018-07-02. Completion: 2019-05-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug)
Misoprostol (drug)

Where the study takes place — 1 listed sites

Kasr Alainy medical school
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Early Phase 1CompletedINTERVENTIONAL

Carbetocin Versus Oxytocin for Prevention of Postcesarean Hemorrhage in Pregnancy With High Risk for PPH

ClinicalTrials.gov · NCT04089176 · Registry updated: 2019-09-13

Condition / research focus: Postpartum Hemorrhage; Cesarean Section; High Risk Pregnancy
Sponsor: Department of Medical Services Ministry of Public Health of Thailand
Countries with listed sites: Thailand
Registry dates and results: Start: 2019-02-01. Completion: 2019-05-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug)
oxytocin (drug)

Where the study takes place — 1 listed sites

Rajavithi Hospital
Bangkok, Thailand
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Carbetocin at Elective Cesarean Deliveries: A Dose-finding Study in Women With BMI ≥ 40kg/m2

ClinicalTrials.gov · NCT03672045 · Registry updated: 2019-06-07

Condition / research focus: Postpartum Hemorrhage
Sponsor: Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Countries with listed sites: Canada
Registry dates and results: Start: 2018-11-19. Completion: 2019-05-17 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug) — also listed as: Duratocin

Where the study takes place — 1 listed sites

Mount Sinai Hospital
Toronto, Ontario, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Database Evaluating Outcomes of Using Carbetocin as the Primary Uterotonic Following Cesarean Delivery

ClinicalTrials.gov · NCT03959436 · Registry updated: 2019-05-29

Condition / research focus: Carbetocin; Cesarean Section Complications; Uterotonics; Uterine Atony With Hemorrhage
Sponsor: Maisonneuve-Rosemont Hospital
Countries with listed sites: Canada
Registry dates and results: Start: 2017-03-29. Completion: 2018-03-16 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug) — also listed as: Duratocin

Where the study takes place — 1 listed sites

Maisonneuve-Rosemont hospital
Montreal, Quebec, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableUnknownOBSERVATIONAL

Effects of Oxytocin and Carbetocin on Renal System in Cesarean Sections

ClinicalTrials.gov · NCT03939806 · Registry updated: 2019-05-13

Condition / research focus: Postpartum Hemorrhage
Sponsor: Ufuk University
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2019-05. Completion: 2019-06 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
Carbetocin (drug)

Where the study takes place — 1 listed sites

Ufuk University Faculty of Medicine Hospital
Ankara, Balgat, Turkey (Türkiye)
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Carbetocin Versus Oxytocin Infusion Plus Tranexamic Acid During Cesarean Section

ClinicalTrials.gov · NCT03777878 · Registry updated: 2019-02-15

Condition / research focus: Cesarean Section Complications
Sponsor: Aswan University Hospital
Countries with listed sites: Egypt
Registry dates and results: Start: 2019-01-01. Completion: 2021-05-01 (may be estimated). No results posted in this registry response.

Products and interventions (6)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug) — also listed as: Active Comparator
oxytocin (drug) — also listed as: Active Comparator
TA (drug) — also listed as: active comparator
placebo to carbetocin (drug) — also listed as: placebo comparator
placebo to TA (drug) — also listed as: placebo comparator
placebo to oxytocin (drug) — also listed as: placebo comparator

Where the study takes place — 1 listed sites

Aswan University
Aswān, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Carbetocin Versus Oxytocin for the Prevention of Postpartum Hemorrhage in Emergency Caesarean Delivery

ClinicalTrials.gov · NCT03755531 · Registry updated: 2018-11-28

Condition / research focus: Postpartum Hemorrhage (Primary)
Sponsor: Al-Kindy College of Medicine
Countries with listed sites: Iraq
Registry dates and results: Start: 2018-01-04. Completion: 2018-08-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug) — also listed as: BABAL
Oxytocin (drug) — also listed as: Pitocin

Where the study takes place — 1 listed sites

Al Kindy College of Medicine/ University of Baghdad
Baghdad, Iraq
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Intramuscular Oxytocics: A Randomised Control Trial

ClinicalTrials.gov · NCT02216383 · Registry updated: 2018-11-14

Condition / research focus: Post Partum Haemorrhage
Sponsor: North Bristol NHS Trust
Countries with listed sites: United Kingdom
Registry dates and results: Start: 2015-02. Completion: 2018-10-30 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug) — also listed as: Pabal
Syntocinon (drug) — also listed as: Oxytocin
Syntometrine (drug) — also listed as: Syntometrine 500 micrograms/5 IU Solution for Injection

Where the study takes place — 5 listed sites

North Bristol NHS Trust
Bristol, Avon, United Kingdom
Site recruitment: Not reported
Gloucestershire Hospitals NHS Trust
Gloucester, Gloucestershire, United Kingdom
Site recruitment: Not reported
Royal United Hospital NHS Trust
Bath, Somerset, United Kingdom
Site recruitment: Not reported
Nottingham University Hospitals NHS Trust
Nottingham, United Kingdom
Site recruitment: Not reported
Great Western Hospital
Swindon, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Effect of the Uterotonic Carbetocin on Acute Post Cesarean-Section Pain

ClinicalTrials.gov · NCT02642263 · Registry updated: 2018-05-04

Condition / research focus: Cesarean Delivery
Sponsor: Insel Gruppe AG, University Hospital Bern
Countries with listed sites: Switzerland
Registry dates and results: Start: 2019-02-01. Completion: 2022-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug) — also listed as: Pabal, Ferring, Baar, Switzerland

Where the study takes place — 1 listed sites

Dep. of Anesthesiology and Pain Medicine, Bern University Hospital
Bern, Switzerland
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Carbetocin Trial: Carbetocin Appropriate Rate Better Equilibrium Between Tonus (TOnus) and CIrculatioN

ClinicalTrials.gov · NCT02221531 · Registry updated: 2018-01-09

Condition / research focus: Complications; Cesarean Section; Anesthesia; Reaction
Sponsor: University Hospital, Basel, Switzerland
Countries with listed sites: Switzerland
Registry dates and results: Start: 2014-08. Completion: 2015-11 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin Short-infusion (drug)
Carbetocin Bolus application (drug)

Where the study takes place — 1 listed sites

University Hospital Basel
Basel, Switzerland
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Prevention of Postpartum Hemorrhage in Patients With Severe Preeclampsia Using Carbetocin Versus Misoprostol

ClinicalTrials.gov · NCT02086994 · Registry updated: 2017-02-15

Condition / research focus: Severe Pre-eclampsia, Postpartum Condition or Complication
Sponsor: khalid abd aziz mohamed
Countries with listed sites: Egypt
Registry dates and results: Start: 2013-03. Completion: 2015-08 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

misoprostol (drug) — also listed as: misoprost, cytotec, misotec
carbetocin (drug) — also listed as: pabal

Where the study takes place — 1 listed sites

Benha univesity hospital
Banhā, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Carbetocin and Oxytocin in Elective Caesarean Section With High Risk of Postpartum Hemorrhage

ClinicalTrials.gov · NCT02391636 · Registry updated: 2017-01-25

Condition / research focus: Postpartum Hemorrhage
Sponsor: Ghamra Military Hospital
Countries with listed sites: Egypt
Registry dates and results: Start: 2015-02. Completion: 2016-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug) — also listed as: Pabal
Oxytocin (drug) — also listed as: Syntocinon

Where the study takes place — 1 listed sites

Ghamra Military Hospital
Cairo, Cairo Governorate, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3UnknownINTERVENTIONAL

Carbetocin Versus Oxytocin in the Prevention of Post Partum Haemorrhage (PPH) in Women Undergoing Caesarean Sections for Placenta Previa: A Randomised Controlled Trial

ClinicalTrials.gov · NCT02303418 · Registry updated: 2017-01-23

Condition / research focus: Post Partum Haemorrhage
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2014-11. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug)
Oxytocin (drug)

Where the study takes place — 2 listed sites

BeniSuef University hospitals
BeniSuef, Egypt
Site recruitment: Recruiting
Cairo university hospitals
Cairo, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →